Yahoo Finance • 15 days ago

Repligen (RGEN) Q2 Earnings: What To Expect

Repligen (RGEN) Q2 Earnings: What To Expect Biopharma manufacturing company Repligen Corporation (NASDAQ:RGEN) will be reporting results this Tuesday morning. Here's what you need to know. Repligen beat analysts' revenue expectations las... Full story

Yahoo Finance • 16 days ago

Notable healthcare headlines for the week: Eli Lilly, Molina Healthcare, and Roche in focus

Wall Street's major averages aimed to go higher on Friday but closed mixed as oil prices declined. The benchmark S&P 500 (SP500 [https://seekingalpha.com/symbol/SP500#source=url_first_level%3Amarket-news%7Csection%3Amarket-news%7Csection_... Full story

Yahoo Finance • 20 days ago

Repligen to buy BioLife in $1.5 billion deal to expand cell therapy business

July 22 (Reuters) - Repligen Corp said on Wednesday it would buy BioLife Solutions in a cash-and-stock deal valued at ‌about $1.5 billion, to expand the drugmaking equipment provider's presence in ‌the fast-growing cell therapy market. Th... Full story

Yahoo Finance • 27 days ago

Repligen to Report Second Quarter 2026 Financial Results

WALTHAM, Mass., July 15, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), today announced that the Company will report its second quarter 2026 financial results on Tuesday, July 28, 2026. The Company will issue a press releas... Full story

Yahoo Finance • last month

Here Are Tuesday’s Best Wall Street Analyst Research Calls: Adobe, American Airlines, Broadcom, First Solar, Meta Platforms, Shopify, Space-X, Ventas, Waste Managment, and More

Quick Read The Nasdaq surged 1.12% to 26,121 and the S&P 500 gained 0.72% to 7,537, as chip stocks led a broad rally fueled by easing inflation fears. $ADBE was slashed to Underperform at Bank of America while $SPCX drew Buy ratings from... Full story

Yahoo Finance • last month

William Blair updates conviction list: Oracle in, Meta out and more

[Technology background image, graph, displaying analytical data about stock trading.] Donny DBM William Blair added Oracle (ORCL [https://seekingalpha.com/symbol/ORCL]), American Express (AXP [https://seekingalpha.com/symbol/AXP]), Ecolab... Full story

Yahoo Finance • last month

Here’s Why Repligen Corp. (RGEN) Fell 28% in Q1

TimesSquare Capital Management, an equity investment management company, released its "U.S. Mid Cap Growth Strategy" first-quarter 2026 investor letter. A copy of the letter can be downloaded here. The Strategy fell 7.72% (net) in the quar... Full story

Yahoo Finance • 2 months ago

Repligen (RGEN) Dropped Following the Earnings Release

Brown Capital Management, an investment management company, released its first quarter 2026 investor letter for "The Brown Capital Management Small Company Fund". A copy of the letter can be downloaded here. In the first quarter of 2026, t... Full story

Yahoo Finance • 2 months ago

2 Profitable Stocks on Our Watchlist and 1 Facing Challenges

2 Profitable Stocks on Our Watchlist and 1 Facing Challenges While profitability is essential, it doesn't guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies — as Jeff Bezos s... Full story

Yahoo Finance • 2 months ago

Repligen Corporation (RGEN) Slid on Softened Enthusiasm for Life Sciences Tools

Osterweis Capital Management, an investment management firm, released its Q1 2026 investor update for its "Osterweis Opportunity Fund". A copy of the letter can be downloaded here. The fund returned -3.78% in the quarter compared to -2.81%... Full story

Yahoo Finance • 3 months ago

3 Stocks That May Be Trading Below Their Estimated Value In May 2026

The United States market has experienced a flat week but has shown significant growth over the past year with a 27% increase, and earnings are anticipated to grow by 17% annually. In this context, identifying stocks that may be trading bel... Full story

Yahoo Finance • 3 months ago

Hedge Funds Followed the April Equity Rally by Increasing Exposure to Technology Leaders, Hazeltree Finds

Strong interest in Meta and Amazon.com contrasted with declining Nvidia positioning and continued bearish sentiment toward Tesla NEW YORK & LONDON, May 20, 2026--(BUSINESS WIRE)--Despite geopolitical turbulence and a mix of high volatilit... Full story

Yahoo Finance • 3 months ago

Repligen Announces Publication of the Company’s 2025 Corporate Sustainability Report

Repligen Corporation WALTHAM, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the digital publication of its 2025 Corporat... Full story

Yahoo Finance • 3 months ago

Why Repligen (RGEN) Stock Is Trading Up Today

What Happened? Shares of biopharma manufacturing company Repligen Corporation (NASDAQ:RGEN) jumped 2.9% in the afternoon session after RBC Capital resumed coverage on the stock with an "outperform" rating and a price target of $160. The... Full story

Yahoo Finance • 3 months ago

1 Growth Stock with Explosive Upside and 2 Facing Headwinds

Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle. The risks that can come from buying these asse... Full story

Yahoo Finance • 3 months ago

Barclays Maintains an “Overweight Rating” on Repligen Corporation (RGEN)

Repligen Corporation (NASDAQ:RGEN) is one of the 10 Best Biotech Stocks to Invest In According to Billionaire Steve Cohen. On May 7, Barclays raised Repligen Corporation (NASDAQ:RGEN)’s price goal to $160 from $145. It maintained an “Ove... Full story

Yahoo Finance • 3 months ago

Repligen (RGEN) Q1 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Tuesday, May 5, 2026 at 8 a.m. ET CALL PARTICIPANTS Chief Executive Officer — Olivier LoeillotChief Financial Officer — Jason Garland TAKEAWAYS Revenue -- $194 million reported, representing 15% gr... Full story

Yahoo Finance • 3 months ago

Repligen Reports First Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance

First quarter revenue of $194 million, a year-over-year increase of 15% as reported and 11% organicGAAP EPS increased 50% year-over-year and adjusted EPS increased 23% year-over-yearReiterating FY26 organic revenue growth guidance of 9%-13... Full story

Yahoo Finance • 3 months ago

Tempered Forward Expectations Hurt Repligen Corp. (RGEN) in Q1

Conestoga Capital Advisors, an asset management company, released its first-quarter 2026 investor letter. A copy of the letter can be downloaded here. The first quarter of 2026 began with optimism about the domestic economy and attractive... Full story

Yahoo Finance • 4 months ago

Here’s What Positioned Repligen Corporation (RGEN) for a Durable Long-Term Growth

Fred Alger Management, an investment management company, released its “Alger Mid Cap Fund” first-quarter 2025 investor letter. A copy of the letter can be downloaded here. In the first quarter of 2026, Class A shares of the Alger Mid Cap F... Full story